A biomarker is a molecule or gene with the help of which pathogenic procedures, pharmacologic responses, and biological procedures can be effectively and accurately measured and evaluated. Biomarkers assist medical professionals to take effective clinical decisions and help in diagnosing the health of the patients. Currently, biomarkers are commonly used to treat diseases such as cancer. Extensive use of biomarkers in treating diseases such as cancer is expected to drive the global biomarkers market during the period from 2012 to 2018.
The leading players in the global biomarkers market are expected to face high level of competition from the new entrants in coming few years. The prominent players in the global biomarkers market need to stay updated with changing trends and market challenges in order to stay ahead of the competition.
The global biomarkers marker report highlights factors boosting the market, its major restraints, market opportunities, future predictions, and the industry structure. Details such as key development areas, leading players, changing trends, and competitive analysis mentioned in the report make it the perfect blueprint of the global biomarkers market for stakeholders and the businesses operating in it. Presenting a 360-degree viewpoint, the analysts have used the Porter’s five forces model to measure the competitive analysis and other dynamics of the market. A detailed overview of the micro and macro factors affecting the growth of the market is mentioned in the global biomarkers market report.
Overview of the Biomarkers Market
The global biomarkers market was valued at US$13.1 bn in 2011 and is predicted to reach US$34 bn by 2018. The global biomarkers market is expected to expand at a 14.70% CAGR from 2011 to 2018. The oncology segment of the global biomarkers market is predicted to expand at a 16.32% CAGR during the period from 2011 to 2018. By region, the global biomarkers market is divided into Europe, Asia Pacific, North America, and Rest of the World. North America is expected to be the fastest growing regional market during the forecast period. Factors such as the high acceptance rate of advanced technologies, new product launches, entry of new players, and wider use of biomarkers are expected to propel the North America biomarkers market till 2018.
Rapid growth of the IT industry, the rapidly growing global population, and increasing efforts of drug discovery are some of the factors driving the global biomarkers market. Entry of new players is expected to create new opportunities for the global biomarkers market. Demand for biomarkers is expected to increase further due to their use in medical areas such as cancer treatment and research.
Companies mentioned in the research report
Some of the prominent players in the global biomarker market are Agilent Technologies Inc., Becton, Dickinson and Company, Abbott Laboratories, Bruker Corporation, Epigenomics AG, Celera Corporation, DiagnoCure Inc., and GE Healthcare. With the entry of new companies in the global biomarkers market, the leading companies are expected to face high level of competition in the next few years.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments